Efficiency of olopatadine hydrochloride 0.1% in the treatment of vernal keratoconjunctivitis and goblet cell density

Journal of Ocular Pharmacology and Therapeutics

Volumn 21, Issue 5, 2005, Pages 400-405

  Çorum, Işik ^a   Yeniad, Bariş ^a   Bilgin, Lale Közer ^a   Ilhan, Ridvan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

OLOPATADINE;

ADULT; ARTICLE; CELL COUNT; CELL DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOLOGY; DISEASE SEVERITY; FEMALE; GOBLET CELL; HUMAN; MALE; VERNAL CONJUNCTIVITIS;

ADULT; CELL COUNT; CELL DEGRANULATION; CONJUNCTIVITIS, ALLERGIC; DIBENZOXEPINS; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MAST CELLS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 27544435834     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2005.21.400     Document Type: Article

References (25)

1. Friedlaender, M.H. Ocular allergy. J. Allergy Clin. Immunol. 76:645-657, 1985.
2. Trocme, S.D., Raizman, M.B., and Bartley, G.B. Medical therapy for ocular allergy. Mayo Clin. Proc. 67:557-565, 1992.
3. Abelson, M.B., Madiwale, N., and Weston, J.H. Conjunctival eosinophils in ocular allergic ocular disease. Am. J. Ophthalmol. 101:555-556, 1983.
4. Reed, C.E., and Friedlaender, M.H. Immunologic aspects of diseases of the eye. J. Am. Med. Assoc. 248:2692-2695, 1982.
5. Fujishima, H., Saito, I., Takeuchi, T., et al. Immunological characteristics of patients with vernal keratoconjunctivitis. Jpn. J. Ophthalmol. 46:244-248, 2002.
6. Bonini, S., Bonini, S., Schiavone, M., et al. Conjunctival hyper-responsiveness to ocular histamine challenge in patients with vernal keratoconjunctivitis. J. Allergy Clin. Immunol. 89:103-107, 1992.
7. Bonini, S. IgE and non-IgE mechanisms in ocular allergy. Ann. Allergy 71:296-299, 1993.
8. Banini, S., Coassin, M., Aronni, S., and Lambiase, A. Vernal keratoconjunctivitis. Eye 18:345-351, 2004.
9. Nelson, J.D., and Wright, J.C. Conjunctival goblet cell densities in ocular surface disease. Arch. Ophthalmol. 102:1049-1051, 1984.
10. Kinoshita, S., Kiorpes, T.C., and Friend, J. Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch. Ophthalmol. 101:1284-1287, 1983.
11. Ralph, R.A. Conjunctival goblet cell density in normal subjects and in dry eye syndromes. Invest. Ophthalmol. Vis. Sci. 14:229-302, 1975.
12. Aragona, P., Romeo, G.F., Puzzola, D., et al. Impression cytology of conjunctival epithelium of vernal conjunctivitis. Eye 10:82-85, 1996.
13. Colonge, M.C., Pastor, J.C., Herreras, J.M., and Gonzalez, J.L. Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest. Ophthalmol. Vis. Sci. 31:176-180, 1990.
14. Dogru, M., Ozmen, A., Erturk, H., Sanli, O., and Karatas, A. Changes in tear function and the ocular surface after topical olopatadine treatment for allergic conjunctivitis: An open-label study. Clin. Ther. 24:1329-1321, 2002
15. Friedlaender, M. Overview of ocular allergy treatment. Curr. Allergy Asthma Rep. 1:375-379, 2001.
16. Caldwell, D.R., Verin, P., Hartwich-Young, R., et al. Efficacy and safety of lodoxamid 0.1% in patients with vernal keratoconjunctivitis. Am. J. Ophthalmol. 113:632-637, 1992.
17. Abelson, M.B. Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge model. Ann. Allergy Asthma Immunol. 81:211-218, 1998.
18. Tsubota, K., Takamura, E., Hasegawa, T., et al. Detection by brush cytology of mast cells and eosinophils in allergic and vernal conjunctivitis. Cornea 10:525-531, 1991.
19. Allansmith, M.R., and Ross, R.N. Ocular allergy and mast cell stabilizers. Surv. Ophthalmol. 30:229-244, 1986.
20. Abelson, M.B., and Welch, D.L. An evaluation of onset and duration of action of patanol (olopatadine hydrochloride ophthalmic solution, 0.1%) compared to claritin (loratadine 10 mg tablets) tablets in acute allergic conjunctivitis in the conjunctival allergen challenge model. Acta. Ophthalmol. Scand. (Suppl) 78:65-66, 2000.
21. Spencer, W.H., and Zimmerman, L.E. Conjunctiva. In: Ophthalmic Pathology: An Atlas and Textbook, Vol. 1, Chap. 2, 3rd ed. Spencer, W.H., ed. Philadelphia: W.B. Saunders, 1985:148-151.
22. Tseng, S.C.G., Hirst, L.W., and Maumenee, A.E. Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology 91:545-552, 1984.
23. Spangler, D.I., Bensch, G., and Berdy, G.J. Evaluation of the efficacy of olopatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clin. Ther. 23:1272-1280, 2001.
24. Yaylali, V., Demirlenk, I., Tathpinar, S., Özbay, D., et al. Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketoralak tromethamine in the treatment of seasonal allergic conjunctivitis. Acta. Ophthalmol. Scand. 81:378-382, 2003.
25. Bridsky, M., Berger, W.E., Butrus, S., Epstein, A.B., and İrkeç, M. Evaluation of comfort using olopatadine hydrochloride 0.1% ophthalmic solution in the treatment of allergic conjunctivitis in contact lens wearers compared to placebo using the conjunctival allergen chalenge model. Eye Contact Lens 29:113-116, 2003.